openPR Logo
Press release

Drug Delivery Devices Market Outlook, Growth Strategy With BD, 3M, Crossject, Merck Group, Roche, Novartis, Bayer, Abbott Healthcare, Sanofi, Pfizer, Alkermes, Baxter International, Inc., Johnson & Johnson

05-24-2019 02:30 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Drug Delivery Devices Market

Drug Delivery Devices Market

Global drug delivery devices market is expected to rise from its initial estimated value of USD 1243.34 billion in 2018 to a projected value of USD 2070.12 billion by 2026, registering a CAGR of 6.58% in the forecast period of 2019-2026. This rise in market value can be attributed to the constant innovations and advancements in the market resulting in product launches.

Drug delivery devices market report has been worked out with the thorough statistics and market research insights which provide quick growth and thriving sustainability in the industry for the businesses. In addition, market definition underlined in this drug delivery devices report covers the market drivers which are supposed to make rise in the market and market restraints that causes fall in the market growth. Market analysis carried out in this drug delivery devices report gives estimations about the probable rise, growth or fall of the product in the exact forecast period. Competitive analysis provides a clear idea about the strategies used by the major players in the market which boosts their penetration in the market.

A range of competitor analysis strategies included in drug delivery devices report are; new product launches, expansions, agreements, joint ventures, partnerships, and acquisitions. The market data is explored and forecasted using well known market statistical and coherent models. Market shares of the top market players in the major areas of the world such as Europe, North America, Asia Pacific, South America, Middle East and Africa are also evaluated in this drug delivery devices market research report. Research and analysis in the drug delivery devices report is performed with one step or the combination of several steps depending upon the client and business requirements.

Get Free Sample of This Market Information: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-drug-delivery-devices-market

Market Definition: Global Drug Delivery Devices Market

Drug delivery devices are those medical devices and equipments that are used for dispatching the drugs into the human bodies and various systems. They are specifically made for dispatching the specific drugs according to the various administration techniques. These devices are used for the therapeutic treatments and entire recovery procedure.

Market Drivers:

· Increasing prevalence of chronic diseases globally resulting in increased consumption of therapeutic drugs and therapies; this factor is expected to act as a driver for the market growth

· Growth in the consumption of drugs and therapeutic pharmaceuticals because of the development and better nature of treatment associated with these drugs; this factor is expected to act as a driver for the market growth

Market Restraint:

· Increase in complications and expertise required in delivering therapeutics and drugs through these devices; this factor is expected to act as a restraint to the market growth

Key Market Competitors: Global Drug Delivery Devices Market

BD.; F. Hoffmann-La Roche Ltd; Antares Pharma; Novartis AG; 3M; Sulzer Ltd; Gerresheimer AG; Sanofi; Johnson & Johnson Services, Inc.; Bayer AG; GlaxoSmithKline plc; Novosanis; MEDMIX SYSTEMS AG; Merck & Co., Inc.; Pfizer Inc.; Insulet Corporation; OraSure Technologies, Inc.; Enable Injections; West Pharmaceutical Services, Inc.; SMC Ltd.; ViVO Smart Medical Devices Ltd. and Cipla Inc. are few of the major competitors currently present in the market.

Get TOC For Full Analysis Of Report: https://databridgemarketresearch.com/toc/?dbmr=global-drug-delivery-devices-market

Global drug delivery devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of drug delivery devices market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Segmentation: Global Drug Delivery Devices Market

· By Route of Administration

o Oral Drug Delivery

· Solid Oral Drugs

· Tablets

· Capsules

· Powders

· Pills

· Liquid Oral Drugs

· Syrups

· Solutions

· Semi-Solid Oral Drugs

· Gels

· Emulsions

· Elixirs

o Injectable Drug Delivery

· Conventional Injection Devices (By Material)

· Glass

· Plastic

· Conventional Injection Devices (By Product)

· Fillable Syringes

· Pre-Filled Syringes

· Conventional Injection Devices (By Usability)

· Reusable Syringes

· Disposable Syringes

· Self-Injection Devices

· Needle-Free Injectors

· Autoinjectors

· Pen Injectors

· Wearable Injectors

· Other Injector Devices

o Topical Drug Delivery

· Liquid Formulations

· Solutions

· Suspensions

· Semi-Solid Formulations

· Creams

· Gels

· Ointments

· Pastes

· Lotions

· Solid Formulations

· Suppositories

· Powders

· Transdermal Products

· Transdermal Patches

· Transdermal Gels

o Ocular Drug Delivery

· Liquid Formulations

· Eye Drops

· Liquid Sprays

· Semi-Solid Formulations

· Gels

· Eye Ointments

· Ocular Devices

· Drug-Coated Contact Lenses

· Ocular Inserts

o Pulmonary Drug Delivery

· Metered-Dose Inhalers

· Dry Powder Inhalers

· Nebulizers

· Jet Nebulizers

· Ultrasonic Nebulizers

· Soft Mist Nebulizers

o Nasal Drug Delivery

· Nasal Drops

· Nasal Sprays

· Nasal Powders

· Nasal Gels

o Transmucosal Drug Delivery

· Oral Formulations

· Buccal Drug Delivery

· Sublingual Drug Delivery

· Others

· Rectal Transmucosal Drug Delivery

· Vaginal Transmucosal Drug Delivery

o Implantable Drug Delivery

· Active Implantable Drug Delivery

· Passive Implantable Drug Delivery

· By Patient Care Setting

o Hospitals

o Diagnostic Centers

o Ambulatory Surgery Centers/Clinics

o Home Care Settings

o Others

· By Application

o Cancer

o Infectious Diseases

o Respiratory Diseases

o Diabetes

o Cardiovascular Diseases

o Autoimmune Diseases

o Central Nervous System Disorders

o Others

· Endocrine Disorders

· Ophthalmic Disorders

· By Geography

o North America

· US.

· Canada

· Mexico

o South America

· Brazil

· Argentina

· Rest of South America

o Europe

· Germany

· France

· United Kingdom

· Italy

· Spain

· Russia

· Turkey

· Belgium

· Netherlands

· Switzerland

· Rest of Europe

o Asia-Pacific

· Japan

· China

· South Korea

· India

· Australia

· Singapore

· Thailand

· Malaysia

· Indonesia

· Philippines

· Rest of Asia Pacific

o Middle East & Africa

· South Africa

· Egypt

· Saudi Arabia

· United Arab Emirates

· Israel

· Rest of Middle East & Africa

Key Developments in the Market:

· In September 2018, Sulzer Ltd announced that they had completed the acquisition of MEDMIX SYSTEMS AG. This acquisition will help Sulzer Ltd in expanding their business segments to include the healthcare division and help in providing various products for the healthcare market.

· In July 2018, Gerresheimer AG announced that they had acquired Sensile Medical and has expanded their service portfolios through this acquisition. This acquisition will help in expanding the technological portfolio of Gerresheimer AG due to Sensile’s expertise in the development and usage of liquid drug delivery devices.

Reasons to Purchase this Report:

· Current and future of global drug delivery devices market outlook in the developed and emerging markets

· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

· Regions/Countries that are expected to witness the fastest growth rates during the forecast period

· The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

· All segmentation provided above in this report is represented at country level

· All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Want Full Report? Enquire Here: https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-drug-delivery-devices-market

About Us

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
https://databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Delivery Devices Market Outlook, Growth Strategy With BD, 3M, Crossject, Merck Group, Roche, Novartis, Bayer, Abbott Healthcare, Sanofi, Pfizer, Alkermes, Baxter International, Inc., Johnson & Johnson here

News-ID: 1752734 • Views: 648

More Releases from Data Bridge Market Research

Global HbA1c Testing Market Size, Share, Growth Analysis, Global Trends, Industr …
Global HbA1c testing market is set to witness a healthy CAGR of 10.25% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing diabetes and rising health awareness among population is the factor for the growth of this market. This HbA1c testing market analysis report endows with the plentiful insights and business solutions that will help to stay ahead of
Europe Ophthalmology Drugs and Devices Market size, Insights, Prospects, Growth …
Ophthalmology drugs & devices market is expected to grow in the forecast period from 2020 to 2027. Data Bridge Market Research analyses the market for USD 13.81 billion by 2027, growing at a CAGR of 5.45% over the above-mentioned forecast period. The growth of Europe ophthalmology drugs & devices market is attributed to growing incidences of eye diseases. The ophthalmology drugs & devices market report aids to concentrate on the important
Global Foot Orthotic Insoles Market Incredible Possibilities, Growth With Indust …
Global foot orthotic insoles market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 5.76 Billion by 2027 growing at a CAGR of 6.04% in the above mentioned forecast period. The growth of foot orthotic insoles market is growing due to rise in occurrence of people suffering from arthritis, increase in geriatric and obese
Global Next-Generation Biomanufacturing Market 2020-2027 Detailed Analysis of Cu …
Next-generation biomanufacturing market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to growing at a CAGR of 9.8% in the above-mentioned forecast period. The growing awareness among the people regarding the benefits next-generation biomanufacturing which will further boost various lucrative opportunities will lead to the growth of the market. Next-generation biomanufacturing market research report takes into consideration several

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning